Galapagos bowel drug fails in research trial 26.01.2016 10:22 Reuters BRUSSELS (Reuters) - Belgian biotech group Galapagos said its experimental drug to treat bowel disease ulcerative colitis had failed to prove its efficacy in a medical trial and it would discontinue the program for that disease.
